NCT00414128 - Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis | Biotech Hunter

Enrollment

140

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

February 28, 2013

Conditions

Vasculitis

Interventions

DRUG

mycophenolate mofetil

2-3g/day for 3-6 months, in tablet, capsule or liquid form

DRUG

cyclophosphamide

intravenous cyclophosphamide, 15mg/kg with dose reductions according to age and renal function, for 3-6 months (6-10 doses total)

Trial Locations (1)

Addenbrookes Hospital, Cambridge